메뉴 건너뛰기




Volumn 12, Issue , 2012, Pages

Risk of new acute myocardial infarction hospitalization associated with use of oral and parenteral non-steroidal anti-inflammation drugs (NSAIDs): A case-crossover study of Taiwan's National Health Insurance claims database and review of current evidence

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACEMETACIN; ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CELECOXIB; DICLOFENAC; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLURBIPROFEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IBUPROFEN; INDOMETACIN; INSULIN; KETOPROFEN; KETOROLAC; LOOP DIURETIC AGENT; MEFENAMIC ACID; MELOXICAM; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; SULFONYLUREA; SULINDAC; PROSTAGLANDIN SYNTHASE INHIBITOR;

EID: 84856449219     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-12-4     Document Type: Article
Times cited : (51)

References (67)
  • 1
    • 65249190314 scopus 로고    scopus 로고
    • An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs
    • 10.1016/j.amjcard.2009.01.014, 19406264
    • Farkouh ME, Greenberg BP. An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs. Am J Cardiol 2009, 103(9):1227-1237. 10.1016/j.amjcard.2009.01.014, 19406264.
    • (2009) Am J Cardiol , vol.103 , Issue.9 , pp. 1227-1237
    • Farkouh, M.E.1    Greenberg, B.P.2
  • 2
    • 37349123992 scopus 로고    scopus 로고
    • Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin?
    • 10.1016/S0140-6736(07)61909-6, 18156036
    • Strand V. Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin?. Lancet 2007, 370(9605):2138-2151. 10.1016/S0140-6736(07)61909-6, 18156036.
    • (2007) Lancet , vol.370 , Issue.9605 , pp. 2138-2151
    • Strand, V.1
  • 3
    • 33744976771 scopus 로고    scopus 로고
    • Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials
    • 10.1136/bmj.332.7553.1302, 1473048, 16740558
    • Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ 2006, 332(7553):1302-1308. 10.1136/bmj.332.7553.1302, 1473048, 16740558.
    • (2006) BMJ , vol.332 , Issue.7553 , pp. 1302-1308
    • Kearney, P.M.1    Baigent, C.2    Godwin, J.3    Halls, H.4    Emberson, J.R.5    Patrono, C.6
  • 4
    • 39049149403 scopus 로고    scopus 로고
    • Cyclooxygenase-2 inhibitors and most traditional nonsteroidal anti-inflammatory drugs cause similar moderately increased risks of cardiovascular disease
    • 10.1177/1074248407312990, 18287589
    • Hennekens CH, Borzak S. Cyclooxygenase-2 inhibitors and most traditional nonsteroidal anti-inflammatory drugs cause similar moderately increased risks of cardiovascular disease. J Cardiovasc Pharmacol Ther 2008, 13(1):41-50. 10.1177/1074248407312990, 18287589.
    • (2008) J Cardiovasc Pharmacol Ther , vol.13 , Issue.1 , pp. 41-50
    • Hennekens, C.H.1    Borzak, S.2
  • 5
    • 44149106595 scopus 로고    scopus 로고
    • Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation
    • Chen YF JP, Barton P, Bryan S, Fry-Smith A, Harris G, Taylor RS. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. Health Technol Assess 2008, 12(11):1-278.
    • (2008) Health Technol Assess , vol.12 , Issue.11 , pp. 1-278
    • Chen YF, J.P.1    Barton, P.2    Bryan, S.3    Fry-Smith, A.4    Harris, G.5    Taylor, R.S.6
  • 6
    • 54549100296 scopus 로고    scopus 로고
    • The Editor's Roundtable: Nonsteroidal Antiinflammatory Drugs and Cardiovascular Risk
    • 10.1016/j.amjcard.2008.08.004, 18929707
    • Friedewald VE, Bennett JS, Packer M, Roberts WC, Williams GW. The Editor's Roundtable: Nonsteroidal Antiinflammatory Drugs and Cardiovascular Risk. The American Journal of Cardiology 2008, 102(8):1046-1055. 10.1016/j.amjcard.2008.08.004, 18929707.
    • (2008) The American Journal of Cardiology , vol.102 , Issue.8 , pp. 1046-1055
    • Friedewald, V.E.1    Bennett, J.S.2    Packer, M.3    Roberts, W.C.4    Williams, G.W.5
  • 7
    • 63449135133 scopus 로고    scopus 로고
    • Cardiovascular risk associated with nonsteroidal anti-inflammatory drugs
    • 10.1007/s11926-009-0005-5, 19171109
    • Hermann M. Cardiovascular risk associated with nonsteroidal anti-inflammatory drugs. Curr Rheumatol Rep 2009, 11(1):31-35. 10.1007/s11926-009-0005-5, 19171109.
    • (2009) Curr Rheumatol Rep , vol.11 , Issue.1 , pp. 31-35
    • Hermann, M.1
  • 8
    • 53049091589 scopus 로고    scopus 로고
    • Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk
    • 10.1016/j.ccl.2008.06.004, 18929233
    • Vardeny O, Solomon SD. Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk. Cardiol Clin 2008, 26(4):589-601. 10.1016/j.ccl.2008.06.004, 18929233.
    • (2008) Cardiol Clin , vol.26 , Issue.4 , pp. 589-601
    • Vardeny, O.1    Solomon, S.D.2
  • 9
    • 33749614598 scopus 로고    scopus 로고
    • Use of Non-Aspirin Nonsteroidal Antiinflammatory Drugs and the Risk of Cardiovascular Events
    • 10.1345/aph.1H048, 16985093
    • Cheng JW. Use of Non-Aspirin Nonsteroidal Antiinflammatory Drugs and the Risk of Cardiovascular Events. Ann Pharmacother 2006, 40(10):1785-1796. 10.1345/aph.1H048, 16985093.
    • (2006) Ann Pharmacother , vol.40 , Issue.10 , pp. 1785-1796
    • Cheng, J.W.1
  • 10
    • 33845702374 scopus 로고    scopus 로고
    • Risk of Cardiovascular Events in Patients Receiving Celecoxib: A Meta-Analysis of Randomized Clinical Trials
    • 10.1016/j.amjcard.2006.07.069, 17196469
    • White WB, West CR, Borer JS, Gorelick PB, Lavange L, Pan SX, Weiner E, Verburg KM. Risk of Cardiovascular Events in Patients Receiving Celecoxib: A Meta-Analysis of Randomized Clinical Trials. The American Journal of Cardiology 2007, 99(1):91-98. 10.1016/j.amjcard.2006.07.069, 17196469.
    • (2007) The American Journal of Cardiology , vol.99 , Issue.1 , pp. 91-98
    • White, W.B.1    West, C.R.2    Borer, J.S.3    Gorelick, P.B.4    Lavange, L.5    Pan, S.X.6    Weiner, E.7    Verburg, K.M.8
  • 11
    • 33749339372 scopus 로고    scopus 로고
    • Cardiovascular Risk and Inhibition of Cyclooxygenase: A Systematic Review of the Observational Studies of Selective and Nonselective Inhibitors of Cyclooxygenase 2
    • 10.1001/jama.296.13.jrv60011, 16968831
    • McGettigan P, Henry D. Cardiovascular Risk and Inhibition of Cyclooxygenase: A Systematic Review of the Observational Studies of Selective and Nonselective Inhibitors of Cyclooxygenase 2. JAMA 2006, 296(13):1633-1644. 10.1001/jama.296.13.jrv60011, 16968831.
    • (2006) JAMA , vol.296 , Issue.13 , pp. 1633-1644
    • McGettigan, P.1    Henry, D.2
  • 12
    • 33745921486 scopus 로고    scopus 로고
    • Meta-analysis: cardiovascular events associated with nonsteroidal anti-inflammatory drugs
    • 10.1016/j.amjmed.2005.10.056, 16828623
    • Salpeter SR, Gregor P, Ormiston TM, Whitlock R, Raina P, Thabane L, Topol EJ. Meta-analysis: cardiovascular events associated with nonsteroidal anti-inflammatory drugs. Am J Med 2006, 119(7):552-559. 10.1016/j.amjmed.2005.10.056, 16828623.
    • (2006) Am J Med , vol.119 , Issue.7 , pp. 552-559
    • Salpeter, S.R.1    Gregor, P.2    Ormiston, T.M.3    Whitlock, R.4    Raina, P.5    Thabane, L.6    Topol, E.J.7
  • 13
    • 58149286388 scopus 로고    scopus 로고
    • National Health Insurance in Taiwan 2010
    • National Health Insurance in Taiwan 2010. , http://www.nhi.gov.tw/resource/Webdata/Attach_15634_1_National Health Insurance in Taiwan 2010.pdf
  • 14
    • 34547208110 scopus 로고    scopus 로고
    • Nonselective Nonsteroidal Antiinflammatory Drugs and Cardiovascular Risk: Are They Safe?
    • 10.1345/aph.1H341, 17609238
    • Waksman JC, Brody A, Phillips SD. Nonselective Nonsteroidal Antiinflammatory Drugs and Cardiovascular Risk: Are They Safe?. Ann Pharmacother 2007, 41(7):1163-1173. 10.1345/aph.1H341, 17609238.
    • (2007) Ann Pharmacother , vol.41 , Issue.7 , pp. 1163-1173
    • Waksman, J.C.1    Brody, A.2    Phillips, S.D.3
  • 15
    • 34848863617 scopus 로고    scopus 로고
    • Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials
    • 10.1136/ard.2006.068650, 1994282, 17344246
    • Scott PA, Kingsley GH, Smith CM, Choy EH, Scott DL. Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials. Ann Rheum Dis 2007, 66(10):1296-1304. 10.1136/ard.2006.068650, 1994282, 17344246.
    • (2007) Ann Rheum Dis , vol.66 , Issue.10 , pp. 1296-1304
    • Scott, P.A.1    Kingsley, G.H.2    Smith, C.M.3    Choy, E.H.4    Scott, D.L.5
  • 16
    • 36549060159 scopus 로고    scopus 로고
    • Cardiovascular Thromboembolic Adverse Effects Associated with Cyclooxygenase-2 Selective Inhibitors and Nonselective Antiinflammatory Drugs
    • 10.1213/01.ane.0000286229.05723.50, 22315331
    • Joshi GP, Gertler R, Fricker R. Cardiovascular Thromboembolic Adverse Effects Associated with Cyclooxygenase-2 Selective Inhibitors and Nonselective Antiinflammatory Drugs. Anesthesia & Analgesia 2007, 105(6):1793-1804. 10.1213/01.ane.0000286229.05723.50, 22315331.
    • (2007) Anesthesia & Analgesia , vol.105 , Issue.6 , pp. 1793-1804
    • Joshi, G.P.1    Gertler, R.2    Fricker, R.3
  • 18
    • 33747125484 scopus 로고    scopus 로고
    • Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction
    • 10.1161/CIRCULATIONAHA.106.616219, 16785336
    • Gislason GH, Jacobsen S, Rasmussen JN, Rasmussen S, Buch P, Friberg J, Schramm TK, Abildstrom SZ, Kober L, Madsen M, Torp-Pedersen C. Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction. Circulation 2006, 113(25):2906-2913. 10.1161/CIRCULATIONAHA.106.616219, 16785336.
    • (2006) Circulation , vol.113 , Issue.25 , pp. 2906-2913
    • Gislason, G.H.1    Jacobsen, S.2    Rasmussen, J.N.3    Rasmussen, S.4    Buch, P.5    Friberg, J.6    Schramm, T.K.7    Abildstrom, S.Z.8    Kober, L.9    Madsen, M.10    Torp-Pedersen, C.11
  • 19
    • 70549111209 scopus 로고    scopus 로고
    • Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease
    • 10.1002/pds.1820, 19637402
    • Roumie CL, Choma NN, Kaltenbach L, Mitchel EF, Arbogast PG, Griffin MR. Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease. Pharmacoepidemiology and Drug Safety 2009, 18(11):1053-1063. 10.1002/pds.1820, 19637402.
    • (2009) Pharmacoepidemiology and Drug Safety , vol.18 , Issue.11 , pp. 1053-1063
    • Roumie, C.L.1    Choma, N.N.2    Kaltenbach, L.3    Mitchel, E.F.4    Arbogast, P.G.5    Griffin, M.R.6
  • 20
    • 53549094147 scopus 로고    scopus 로고
    • Does the varied use of NSAIDs explain the differences in the risk of myocardial infarction?
    • 10.1111/j.1365-2796.2008.01991.x, 18624902
    • van Staa TP, Rietbrock S, Setakis E, Leufkens HG, Leufkens HGM. Does the varied use of NSAIDs explain the differences in the risk of myocardial infarction?. Journal of Internal Medicine 2008, 264(5):481-492. 10.1111/j.1365-2796.2008.01991.x, 18624902.
    • (2008) Journal of Internal Medicine , vol.264 , Issue.5 , pp. 481-492
    • van Staa, T.P.1    Rietbrock, S.2    Setakis, E.3    Leufkens, H.G.4    Leufkens, H.G.M.5
  • 21
    • 42149176039 scopus 로고    scopus 로고
    • Onset of acute myocardial infarction after use of non-steroidal anti-inflammatory drugs
    • 10.1002/pds.1560, 18302311
    • Hammad TA, Graham DJ, Staffa JA, Kornegay CJ, Pan GJD. Onset of acute myocardial infarction after use of non-steroidal anti-inflammatory drugs. Pharmacoepidemiology and Drug Safety 2008, 17(4):315-321. 10.1002/pds.1560, 18302311.
    • (2008) Pharmacoepidemiology and Drug Safety , vol.17 , Issue.4 , pp. 315-321
    • Hammad, T.A.1    Graham, D.J.2    Staffa, J.A.3    Kornegay, C.J.4    Pan, G.J.D.5
  • 22
    • 33646470853 scopus 로고    scopus 로고
    • Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: High-risk subgroups and time course of risk
    • 10.1002/art.21887, 22315615
    • Solomon DH, Avorn J, Sturmer T, Glynn RJ, Mogun H, Schneeweiss S. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: High-risk subgroups and time course of risk. Arthritis & Rheumatism 2006, 54(5):1378-1389. 10.1002/art.21887, 22315615.
    • (2006) Arthritis & Rheumatism , vol.54 , Issue.5 , pp. 1378-1389
    • Solomon, D.H.1    Avorn, J.2    Sturmer, T.3    Glynn, R.J.4    Mogun, H.5    Schneeweiss, S.6
  • 25
    • 0037065519 scopus 로고    scopus 로고
    • Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study
    • 10.1016/S0140-6736(02)07370-1, 11809254
    • Ray WA, Stein CM, Hall K, Daugherty JR, Griffin MR, Ray WA, Stein CM, Hall K, Daugherty JR, Griffin MR. Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study. Lancet 2002, 359(9301):118-123. 10.1016/S0140-6736(02)07370-1, 11809254.
    • (2002) Lancet , vol.359 , Issue.9301 , pp. 118-123
    • Ray, W.A.1    Stein, C.M.2    Hall, K.3    Daugherty, J.R.4    Griffin, M.R.5    Ray, W.A.6    Stein, C.M.7    Hall, K.8    Daugherty, J.R.9    Griffin, M.R.10
  • 26
    • 0037027050 scopus 로고    scopus 로고
    • COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease
    • 10.1016/S0140-6736(02)11131-7, 12383990
    • Ray WA, Stein CM, Daugherty JR, Hall K, Arbogast PG, Griffin MR. COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. Lancet 2002, 360(9339):1071. 10.1016/S0140-6736(02)11131-7, 12383990.
    • (2002) Lancet , vol.360 , Issue.9339 , pp. 1071
    • Ray, W.A.1    Stein, C.M.2    Daugherty, J.R.3    Hall, K.4    Arbogast, P.G.5    Griffin, M.R.6
  • 27
    • 1542499460 scopus 로고    scopus 로고
    • The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin
    • 10.1016/j.jacc.2003.08.064, 15028354
    • Kimmel SE, Berlin JA, Reilly M, Jaskowiak J, Kishel L, Chittams J, Strom BL. The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin. Journal of the American College of Cardiology 2004, 43(6):985-990. 10.1016/j.jacc.2003.08.064, 15028354.
    • (2004) Journal of the American College of Cardiology , vol.43 , Issue.6 , pp. 985-990
    • Kimmel, S.E.1    Berlin, J.A.2    Reilly, M.3    Jaskowiak, J.4    Kishel, L.5    Chittams, J.6    Strom, B.L.7
  • 28
    • 16344367721 scopus 로고    scopus 로고
    • Current use of nonsteroidal antiinflammatory drugs and the risk of acute myocardial infarction
    • 10.1592/phco.25.4.503.61021, 15977911
    • Fischer LM, Schlienger RG, Matter CM, Jick H, Meier CR. Current use of nonsteroidal antiinflammatory drugs and the risk of acute myocardial infarction. Pharmacotherapy 2005, 25(4):503-510. 10.1592/phco.25.4.503.61021, 15977911.
    • (2005) Pharmacotherapy , vol.25 , Issue.4 , pp. 503-510
    • Fischer, L.M.1    Schlienger, R.G.2    Matter, C.M.3    Jick, H.4    Meier, C.R.5
  • 29
    • 12344291466 scopus 로고    scopus 로고
    • Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction.[Summary for patients in Ann Intern Med. 2005 Feb 1;142(3):I21; PMID: 15684199]
    • Kimmel SE, Berlin JA, Reilly M, Jaskowiak J, Kishel L, Chittams J, Strom BL. Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction.[Summary for patients in Ann Intern Med. 2005 Feb 1;142(3):I21; PMID: 15684199]. Annals of Internal Medicine 2005, 142(3):157-164.
    • (2005) Annals of Internal Medicine , vol.142 , Issue.3 , pp. 157-164
    • Kimmel, S.E.1    Berlin, J.A.2    Reilly, M.3    Jaskowiak, J.4    Kishel, L.5    Chittams, J.6    Strom, B.L.7
  • 30
    • 77952035460 scopus 로고    scopus 로고
    • Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran community
    • 10.1111/j.1365-2125.2010.03627.x, 2883762, 20565461
    • Mangoni AA, Woodman RJ, Gaganis P, Gilbert AL, Knights KM. Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran community. British Journal of Clinical Pharmacology 2010, 69(6):689-700. 10.1111/j.1365-2125.2010.03627.x, 2883762, 20565461.
    • (2010) British Journal of Clinical Pharmacology , vol.69 , Issue.6 , pp. 689-700
    • Mangoni, A.A.1    Woodman, R.J.2    Gaganis, P.3    Gilbert, A.L.4    Knights, K.M.5
  • 31
    • 55049100980 scopus 로고    scopus 로고
    • Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population
    • 10.1016/j.jacc.2008.08.041, 18992652
    • Garcia Rodriguez LA, Tacconelli S, Patrignani P, Garcia Rodriguez LA, Tacconelli S, Patrignani P. Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population. Journal of the American College of Cardiology 2008, 52(20):1628-1636. 10.1016/j.jacc.2008.08.041, 18992652.
    • (2008) Journal of the American College of Cardiology , vol.52 , Issue.20 , pp. 1628-1636
    • Garcia Rodriguez, L.A.1    Tacconelli, S.2    Patrignani, P.3    Garcia Rodriguez, L.A.4    Tacconelli, S.5    Patrignani, P.6
  • 32
    • 33745767060 scopus 로고    scopus 로고
    • NSAID use and the risk of hospitalization for first myocardial infarction in the general population: a nationwide case? control study from Finland
    • 10.1093/eurheartj/ehl053, 16731535
    • Helin-Salmivaara A, Virtanen A, Vesalainen R, Gronroos JM, Klaukka T, Idanpaan-Heikkila JE, Huupponen R. NSAID use and the risk of hospitalization for first myocardial infarction in the general population: a nationwide case? control study from Finland. European Heart Journal 2006, 27(14):1657-1663. 10.1093/eurheartj/ehl053, 16731535.
    • (2006) European Heart Journal , vol.27 , Issue.14 , pp. 1657-1663
    • Helin-Salmivaara, A.1    Virtanen, A.2    Vesalainen, R.3    Gronroos, J.M.4    Klaukka, T.5    Idanpaan-Heikkila, J.E.6    Huupponen, R.7
  • 33
    • 33646905898 scopus 로고    scopus 로고
    • Increased risk of myocardial infarction as first manifestation of ischaemic heart disease and nonselective nonsteroidal anti-inflammatory drugs
    • 10.1111/j.1365-2125.2006.02644.x, 1885122, 16722837
    • Hawkey CJ, Hawkey GM, Everitt S, Skelly MM, Stack WA, Gray D. Increased risk of myocardial infarction as first manifestation of ischaemic heart disease and nonselective nonsteroidal anti-inflammatory drugs. British Journal of Clinical Pharmacology 2006, 61(6):730-737. 10.1111/j.1365-2125.2006.02644.x, 1885122, 16722837.
    • (2006) British Journal of Clinical Pharmacology , vol.61 , Issue.6 , pp. 730-737
    • Hawkey, C.J.1    Hawkey, G.M.2    Everitt, S.3    Skelly, M.M.4    Stack, W.A.5    Gray, D.6
  • 34
    • 33646182855 scopus 로고    scopus 로고
    • Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction
    • 10.1161/CIRCULATIONAHA.105.602425, 16618816
    • Andersohn F, Suissa S, Garbe E, Andersohn F, Suissa S, Garbe E. Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction. Circulation 2006, 113(16):1950-1957. 10.1161/CIRCULATIONAHA.105.602425, 16618816.
    • (2006) Circulation , vol.113 , Issue.16 , pp. 1950-1957
    • Andersohn, F.1    Suissa, S.2    Garbe, E.3    Andersohn, F.4    Suissa, S.5    Garbe, E.6
  • 35
    • 15944415144 scopus 로고    scopus 로고
    • The risk for myocardial infarction with cyclooxygenase-2 inhibitors: a population study of elderly adults.[Summary for patients in Ann Intern Med. 2005 Apr 5;142(7):I45; PMID: 15809454]
    • Levesque LE, Brophy JM, Zhang B, Levesque LE, Brophy JM, Zhang B. The risk for myocardial infarction with cyclooxygenase-2 inhibitors: a population study of elderly adults.[Summary for patients in Ann Intern Med. 2005 Apr 5;142(7):I45; PMID: 15809454]. Annals of Internal Medicine 2005, 142(7):481-489.
    • (2005) Annals of Internal Medicine , vol.142 , Issue.7 , pp. 481-489
    • Levesque, L.E.1    Brophy, J.M.2    Zhang, B.3    Levesque, L.E.4    Brophy, J.M.5    Zhang, B.6
  • 36
    • 18344368896 scopus 로고    scopus 로고
    • Risk of Hospitalization for Myocardial Infarction Among Users of Rofecoxib, Celecoxib, and Other NSAIDs: A Population-Based Case-Control Study
    • 10.1001/archinte.165.9.978, 15883235
    • Johnsen SP, Larsson H, Tarone RE, McLaughlin JK, Norgard B, Friis S, Sorensen HT. Risk of Hospitalization for Myocardial Infarction Among Users of Rofecoxib, Celecoxib, and Other NSAIDs: A Population-Based Case-Control Study. Arch Intern Med 2005, 165(9):978-984. 10.1001/archinte.165.9.978, 15883235.
    • (2005) Arch Intern Med , vol.165 , Issue.9 , pp. 978-984
    • Johnsen, S.P.1    Larsson, H.2    Tarone, R.E.3    McLaughlin, J.K.4    Norgard, B.5    Friis, S.6    Sorensen, H.T.7
  • 37
    • 22444441665 scopus 로고    scopus 로고
    • Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis
    • 10.1136/bmj.330.7504.1366, 558288, 15947398
    • Hippisley-Cox J, Coupland C. Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ 2005, 330(7504):1366. 10.1136/bmj.330.7504.1366, 558288, 15947398.
    • (2005) BMJ , vol.330 , Issue.7504 , pp. 1366
    • Hippisley-Cox, J.1    Coupland, C.2
  • 38
    • 13444263619 scopus 로고    scopus 로고
    • Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study
    • Graham DJ, Campen D, Hui R, Spence M, Cheetham C, Levy G, Shoor S, Ray WA. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. The Lancet 2005, 365(9458):475-481.
    • (2005) The Lancet , vol.365 , Issue.9458 , pp. 475-481
    • Graham, D.J.1    Campen, D.2    Hui, R.3    Spence, M.4    Cheetham, C.5    Levy, G.6    Shoor, S.7    Ray, W.A.8
  • 39
    • 2442493150 scopus 로고    scopus 로고
    • Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults
    • 10.1161/01.CIR.0000127578.21885.3E, 15096449
    • Solomon DH, Schneeweiss S, Glynn RJ, Kiyota Y, Levin R, Mogun H, Avorn J. Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation 2004, 109(17):2068-2073. 10.1161/01.CIR.0000127578.21885.3E, 15096449.
    • (2004) Circulation , vol.109 , Issue.17 , pp. 2068-2073
    • Solomon, D.H.1    Schneeweiss, S.2    Glynn, R.J.3    Kiyota, Y.4    Levin, R.5    Mogun, H.6    Avorn, J.7
  • 40
    • 3042558200 scopus 로고    scopus 로고
    • Nonsteroidal Antiinflammatory Drugs and the Risk of Myocardial Infarction in the General Population
    • 10.1161/01.CIR.0000132491.96623.04, 15197149
    • Garcia Rodriguez LA, Varas-Lorenzo C, Maguire A, Gonzalez-Perez A. Nonsteroidal Antiinflammatory Drugs and the Risk of Myocardial Infarction in the General Population. Circulation 2004, 109(24):3000-3006. 10.1161/01.CIR.0000132491.96623.04, 15197149.
    • (2004) Circulation , vol.109 , Issue.24 , pp. 3000-3006
    • Garcia Rodriguez, L.A.1    Varas-Lorenzo, C.2    Maguire, A.3    Gonzalez-Perez, A.4
  • 41
    • 0037182008 scopus 로고    scopus 로고
    • Lower Risk of Thromboembolic Cardiovascular Events With Naproxen Among Patients With Rheumatoid Arthritis
    • 10.1001/archinte.162.10.1105, 12020179
    • Watson DJ, Rhodes T, Cai B, Guess HA. Lower Risk of Thromboembolic Cardiovascular Events With Naproxen Among Patients With Rheumatoid Arthritis. Arch Intern Med 2002, 162(10):1105-1110. 10.1001/archinte.162.10.1105, 12020179.
    • (2002) Arch Intern Med , vol.162 , Issue.10 , pp. 1105-1110
    • Watson, D.J.1    Rhodes, T.2    Cai, B.3    Guess, H.A.4
  • 42
    • 0037182013 scopus 로고    scopus 로고
    • Nonsteroidal Anti-inflammatory Drug Use and Acute Myocardial Infarction
    • 10.1001/archinte.162.10.1099, 12020178
    • Solomon DH, Glynn RJ, Levin R, Avorn J. Nonsteroidal Anti-inflammatory Drug Use and Acute Myocardial Infarction. Arch Intern Med 2002, 162(10):1099-1104. 10.1001/archinte.162.10.1099, 12020178.
    • (2002) Arch Intern Med , vol.162 , Issue.10 , pp. 1099-1104
    • Solomon, D.H.1    Glynn, R.J.2    Levin, R.3    Avorn, J.4
  • 43
    • 0036379639 scopus 로고    scopus 로고
    • Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarction
    • 10.1046/j.1365-2125.2002.01637.x, 1874430, 12236854
    • Schlienger RG, Jick H, Meier CR. Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarction. Br J Clin Pharmacol 2002, 54(3):327-332. 10.1046/j.1365-2125.2002.01637.x, 1874430, 12236854.
    • (2002) Br J Clin Pharmacol , vol.54 , Issue.3 , pp. 327-332
    • Schlienger, R.G.1    Jick, H.2    Meier, C.R.3
  • 44
    • 0033933177 scopus 로고    scopus 로고
    • Differential Effects of Aspirin and Non-Aspirin Nonsteroidal Antiinflammatory Drugs in the Primary Prevention of Myocardial Infarction in Postmenopausal Women
    • 10.1097/00001648-200007000-00004, 10874543
    • Garcia Rodriguez LA, Varas C, Patrono C. Differential Effects of Aspirin and Non-Aspirin Nonsteroidal Antiinflammatory Drugs in the Primary Prevention of Myocardial Infarction in Postmenopausal Women. Epidemiology 2000, 11(4):382-387. 10.1097/00001648-200007000-00004, 10874543.
    • (2000) Epidemiology , vol.11 , Issue.4 , pp. 382-387
    • Garcia Rodriguez, L.A.1    Varas, C.2    Patrono, C.3
  • 45
    • 33749495486 scopus 로고    scopus 로고
    • Nonsteroidal antiinflammatory drugs and acute myocardial infarction in patients with no major risk factors
    • 10.1592/phco.26.10.1379, 16999647
    • Jick H, Kaye JA, Russmann S, Jick SS, Jick H, Kaye JA, Russmann S, Jick SS. Nonsteroidal antiinflammatory drugs and acute myocardial infarction in patients with no major risk factors. Pharmacotherapy 2006, 26(10):1379-1387. 10.1592/phco.26.10.1379, 16999647.
    • (2006) Pharmacotherapy , vol.26 , Issue.10 , pp. 1379-1387
    • Jick, H.1    Kaye, J.A.2    Russmann, S.3    Jick, S.S.4    Jick, H.5    Kaye, J.A.6    Russmann, S.7    Jick, S.S.8
  • 46
    • 33846573342 scopus 로고    scopus 로고
    • The coronary risk of cyclo-oxygenase-2 inhibitors in patients with a previous myocardial infarction
    • 1861373, 16849374
    • Brophy JM, Lévesque LE, Zhang B. The coronary risk of cyclo-oxygenase-2 inhibitors in patients with a previous myocardial infarction. Heart 2007, 93(2):189-194. 1861373, 16849374.
    • (2007) Heart , vol.93 , Issue.2 , pp. 189-194
    • Brophy, J.M.1    Lévesque, L.E.2    Zhang, B.3
  • 47
    • 66149086990 scopus 로고    scopus 로고
    • The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs
    • 10.1136/ard.2007.087254, 18495734
    • van der Linden MW, van der Bij S, Welsing P, Kuipers EJ, Herings RMC. The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs. Annals of the Rheumatic Diseases 2009, 68(5):668-673. 10.1136/ard.2007.087254, 18495734.
    • (2009) Annals of the Rheumatic Diseases , vol.68 , Issue.5 , pp. 668-673
    • van der Linden, M.W.1    van der Bij, S.2    Welsing, P.3    Kuipers, E.J.4    Herings, R.M.C.5
  • 49
    • 58849111255 scopus 로고    scopus 로고
    • The case-crossover study design in pharmacoepidemiology
    • 10.1177/0962280208092346, 18765504
    • Delaney JA, Suissa S. The case-crossover study design in pharmacoepidemiology. Stat Methods Med Res 2009, 18(1):53-65. 10.1177/0962280208092346, 18765504.
    • (2009) Stat Methods Med Res , vol.18 , Issue.1 , pp. 53-65
    • Delaney, J.A.1    Suissa, S.2
  • 50
    • 0030831605 scopus 로고    scopus 로고
    • Case-crossover and case-time-control designs as alternatives in pharmacoepidemiologic research
    • Schneeweiss S, Sturmer T, Maclure M. Case-crossover and case-time-control designs as alternatives in pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf 1997, 6(Suppl 3):S51-59.
    • (1997) Pharmacoepidemiol Drug Saf , vol.6 , Issue.SUPPL. 3
    • Schneeweiss, S.1    Sturmer, T.2    Maclure, M.3
  • 51
    • 0025975160 scopus 로고
    • The Case-Crossover Design: A Method for Studying Transient Effects on the Risk of Acute Events
    • Maclure M. The Case-Crossover Design: A Method for Studying Transient Effects on the Risk of Acute Events. Am J Epidemiol 1991, 133(2):144-153.
    • (1991) Am J Epidemiol , vol.133 , Issue.2 , pp. 144-153
    • Maclure, M.1
  • 52
    • 13844290472 scopus 로고    scopus 로고
    • The Anatomical Therapeutic Chemical (ATC) classification system and the Defined Daily Dose (DDD)
    • The Anatomical Therapeutic Chemical (ATC) classification system and the Defined Daily Dose (DDD). , http://www.whocc.no/
  • 55
    • 0034130146 scopus 로고    scopus 로고
    • Minimising the adverse effects of ketorolac
    • 10.2165/00002018-200022060-00007, 10877042
    • Reinhart DJ. Minimising the adverse effects of ketorolac. Drug Saf 2000, 22(6):487-497. 10.2165/00002018-200022060-00007, 10877042.
    • (2000) Drug Saf , vol.22 , Issue.6 , pp. 487-497
    • Reinhart, D.J.1
  • 56
    • 0031053255 scopus 로고    scopus 로고
    • Parenteral ketorolac: The risk for acute renal failure
    • Feldman HI, Kimmel SE. Parenteral ketorolac: The risk for acute renal failure. Annals of Internal Medicine 1997, 126(3):193.
    • (1997) Annals of Internal Medicine , vol.126 , Issue.3 , pp. 193
    • Feldman, H.I.1    Kimmel, S.E.2
  • 57
    • 77956416571 scopus 로고    scopus 로고
    • Increased Risk of Stroke Associated With Nonsteroidal Anti-Inflammatory Drugs: A Nationwide Case-Crossover Study
    • 10.1161/STROKEAHA.110.585828, 20671253
    • Chang C-H, Shau W-Y, Kuo C-W, Chen S-T, Lai M-S. Increased Risk of Stroke Associated With Nonsteroidal Anti-Inflammatory Drugs: A Nationwide Case-Crossover Study. Stroke 2010, 41(9):1884-1890. 10.1161/STROKEAHA.110.585828, 20671253.
    • (2010) Stroke , vol.41 , Issue.9 , pp. 1884-1890
    • Chang, C.-H.1    Shau, W.-Y.2    Kuo, C.-W.3    Chen, S.-T.4    Lai, M.-S.5
  • 58
    • 84862815460 scopus 로고    scopus 로고
    • Department of Health, regulatory document
    • Department of Health, regulatory document.
  • 59
    • 0242472759 scopus 로고    scopus 로고
    • Comparison of the incidence rates of thromboembolic events reported for patients prescribed celecoxib and meloxicam in general practice in England using Prescription-Event Monitoring (PEM) data
    • 10.1093/rheumatology/keg401, 12867585
    • Layton D, Hughes K, Harris S, Shakir SA, Layton D, Hughes K, Harris S, Shakir SAW. Comparison of the incidence rates of thromboembolic events reported for patients prescribed celecoxib and meloxicam in general practice in England using Prescription-Event Monitoring (PEM) data. Rheumatology 2003, 42(11):1354-1364. 10.1093/rheumatology/keg401, 12867585.
    • (2003) Rheumatology , vol.42 , Issue.11 , pp. 1354-1364
    • Layton, D.1    Hughes, K.2    Harris, S.3    Shakir, S.A.4    Layton, D.5    Hughes, K.6    Harris, S.7    Shakir, S.A.W.8
  • 60
    • 20144365496 scopus 로고    scopus 로고
    • Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention
    • 10.1056/NEJMoa050405, 15713944, Adenoma Prevention with Celecoxib Study I
    • Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, Anderson WF, Zauber A, Hawk E, Bertagnolli M, . Adenoma Prevention with Celecoxib Study I Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. New England Journal of Medicine 2005, 352(11):1071-1080. 10.1056/NEJMoa050405, 15713944, Adenoma Prevention with Celecoxib Study I.
    • (2005) New England Journal of Medicine , vol.352 , Issue.11 , pp. 1071-1080
    • Solomon, S.D.1    McMurray, J.J.2    Pfeffer, M.A.3    Wittes, J.4    Fowler, R.5    Finn, P.6    Anderson, W.F.7    Zauber, A.8    Hawk, E.9    Bertagnolli, M.10
  • 61
    • 0041562646 scopus 로고    scopus 로고
    • Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib
    • 10.1016/S0002-9149(03)00659-3, 12914871
    • White WB, Faich G, Borer JS, Makuch RW. Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib. The American Journal of Cardiology 2003, 92(4):411-418. 10.1016/S0002-9149(03)00659-3, 12914871.
    • (2003) The American Journal of Cardiology , vol.92 , Issue.4 , pp. 411-418
    • White, W.B.1    Faich, G.2    Borer, J.S.3    Makuch, R.W.4
  • 62
    • 29144489146 scopus 로고    scopus 로고
    • Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population
    • 10.1186/1741-7015-3-17, 1310534, 16316472
    • Garcia Rodriguez L, Gonzalez-Perez A. Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population. BMC Medicine 2005, 3(1):17. 10.1186/1741-7015-3-17, 1310534, 16316472.
    • (2005) BMC Medicine , vol.3 , Issue.1 , pp. 17
    • Garcia Rodriguez, L.1    Gonzalez-Perez, A.2
  • 65
    • 33845608746 scopus 로고    scopus 로고
    • Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile
    • 10.1002/pds.1343, 17086563
    • Arellano FM, Yood MU, Wentworth CE, Oliveria SA, Rivero E, Verma A, Rothman KJ. Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile. Pharmacoepidemiology and Drug Safety 2006, 15(12):861-872. 10.1002/pds.1343, 17086563.
    • (2006) Pharmacoepidemiology and Drug Safety , vol.15 , Issue.12 , pp. 861-872
    • Arellano, F.M.1    Yood, M.U.2    Wentworth, C.E.3    Oliveria, S.A.4    Rivero, E.5    Verma, A.6    Rothman, K.J.7
  • 66
    • 64849106874 scopus 로고    scopus 로고
    • Defining the problem of treating the patient with hypertension and arthritis pain
    • White WB. Defining the problem of treating the patient with hypertension and arthritis pain. American Journal of Medicine 2009, 122(5 Suppl):S3-9.
    • (2009) American Journal of Medicine , vol.122 , Issue.5 SUPPL
    • White, W.B.1
  • 67
    • 77955627127 scopus 로고    scopus 로고
    • Increased risk of hospitalization for acute hepatitis in patients with previous exposure to NSAIDs
    • 10.1002/pds.1966, 20582911
    • Lee C-H, Wang J-D, Chen P-C. Increased risk of hospitalization for acute hepatitis in patients with previous exposure to NSAIDs. Pharmacoepidemiology and Drug Safety 2010, 19(7):708-714. 10.1002/pds.1966, 20582911.
    • (2010) Pharmacoepidemiology and Drug Safety , vol.19 , Issue.7 , pp. 708-714
    • Lee, C.-H.1    Wang, J.-D.2    Chen, P.-C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.